Literature DB >> 28149637

Updated practice guidelines for the diagnosis and management of aspergillosis: challenges and opportunities.

Michail Alevizakos1, Dimitrios Farmakiotis1, Eleftherios Mylonakis1.   

Abstract

Entities:  

Year:  2016        PMID： 28149637      PMCID： PMC5227220          DOI： 10.21037/jtd.2016.12.71

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  19 in total

1.  Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.

Authors:  Thomas J Walsh; Elias J Anaissie; David W Denning; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; Brahm H Segal; William J Steinbach; David A Stevens; Jo-Anne van Burik; John R Wingard; Thomas F Patterson
Journal:  Clin Infect Dis       Date:  2008-02-01       Impact factor: 9.079

Review 2.  Diagnosis of invasive aspergillosis: recent developments and ongoing challenges.

Authors:  Marios Arvanitis; Eleftherios Mylonakis
Journal:  Eur J Clin Invest       Date:  2015-04-24       Impact factor: 4.686

Review 3.  Diagnostic accuracy of PCR alone compared to galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis: a systematic review.

Authors:  Tomer Avni; Itzhak Levy; Hannah Sprecher; Dafna Yahav; Leonard Leibovici; Mical Paul
Journal:  J Clin Microbiol       Date:  2012-09-05       Impact factor: 5.948

4.  PCR in diagnosis of invasive aspergillosis: a meta-analysis of diagnostic performance.

Authors:  Marios Arvanitis; Panayiotis D Ziakas; Ioannis M Zacharioudakis; Fainareti N Zervou; Angela M Caliendo; Eleftherios Mylonakis
Journal:  J Clin Microbiol       Date:  2014-08-13       Impact factor: 5.948

5.  Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation.

Authors:  John R Wingard; Shelly L Carter; Thomas J Walsh; Joanne Kurtzberg; Trudy N Small; Lindsey R Baden; Iris D Gersten; Adam M Mendizabal; Helen L Leather; Dennis L Confer; Richard T Maziarz; Edward A Stadtmauer; Javier Bolaños-Meade; Janice Brown; John F Dipersio; Michael Boeckh; Kieren A Marr
Journal:  Blood       Date:  2010-09-08       Impact factor: 22.113

6.  Prophylaxis of invasive aspergillosis with voriconazole or caspofungin during building work in patients with acute leukemia.

Authors:  Amélie Chabrol; Lise Cuzin; Françoise Huguet; Muriel Alvarez; Xavier Verdeil; Marie Denise Linas; Sophie Cassaing; Jacques Giron; Laurent Tetu; Michel Attal; Christian Récher
Journal:  Haematologica       Date:  2009-12-08       Impact factor: 9.941

Review 7.  The anti-Aspergillus drug pipeline: Is the glass half full or empty?

Authors:  Nir Osherov; Dimitrios P Kontoyiannis
Journal:  Med Mycol       Date:  2016-08-25       Impact factor: 4.076

8.  Strong correlation between serum aspergillus galactomannan index and outcome of aspergillosis in patients with hematological cancer: clinical and research implications.

Authors:  Marisa H Miceli; Monica L Grazziutti; Gail Woods; Weizhi Zhao; Mehmet H Kocoglu; Bart Barlogie; Elias Anaissie
Journal:  Clin Infect Dis       Date:  2008-05-01       Impact factor: 9.079

9.  Drug-resistant Candida glabrata infection in cancer patients.

Authors:  Dimitrios Farmakiotis; Jeffrey J Tarrand; Dimitrios P Kontoyiannis
Journal:  Emerg Infect Dis       Date:  2014-11       Impact factor: 6.883

Review 10.  Profile of isavuconazole and its potential in the treatment of severe invasive fungal infections.

Authors:  Diego R Falci; Alessandro C Pasqualotto
Journal:  Infect Drug Resist       Date:  2013-10-22       Impact factor: 4.003
View more
  2 in total

1.  Haemorrhagic cystitis following the administration of voriconazole in the treatment of central nervous system aspergillosis: a case report.

Authors:  Zhaohao Zeng; Hong Luo; Kunyu Huang; Lianfang Xue; Hui Liu; Xiaoting Li; Lu Wang; Haimei Cen; Wei Bi; Yu Zhang
Journal:  J Int Med Res       Date:  2020-12       Impact factor: 1.671

2.  Safety and nonclinical and clinical pharmacokinetics of PC945, a novel inhaled triazole antifungal agent.

Authors:  Lindsey Cass; Alison Murray; Amanda Davis; Kathy Woodward; Muna Albayaty; Kazuhiro Ito; Pete Strong; John Ayrton; Charlie Brindley; Jayne Prosser; John Murray; Eddie French; Phillip Haywood; Christopher Wallis; Garth Rapeport
Journal:  Pharmacol Res Perspect       Date:  2021-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.